INTRODUCTION
============

Coronavirus infection has a predilection towards the respiratory system, therefore, chest imaging is frequently used for initial evaluation and follow-up in suspect/confirmed COVID-19 cases in adults. Although RT-PCR is diagnostic for COVID-19, chest imaging has been used extensively for prediction and prognostication of the disease. Some of the findings can be seen on computerized tomography (CT) even before the onset of symptoms \[[@fmaa045-B1]\]. Due to the mild pattern of disease in children findings are usually subtle when compared with adults, and therefore may not be detected on chest X-ray \[[@fmaa045-B2]\]. Thorough knowledge of the choice of imaging modality and radiological findings in various stages of the disease shall help the paediatricians in early recognition and appropriate clinical management. Therefore, we aimed to compile the radiological findings of COVID-19 pneumonia in children in a systematic manner.

MATERIALS AND METHODS
=====================

Search strategy
---------------

We conducted a comprehensive literature search using PubMed, EMBASE, Web of Science and Cochrane library for the original articles published between 01 December 2019 and 20 May 2020. This study was conducted following the Meta-analysis Of Observational Studies in Epidemiology guidelines \[[@fmaa045-B3]\]. Keywords and MeSH terms used for literature search were COVID -19, coronavirus, SARS-CoV-2, 2019-nCoV, severe acute respiratory syndrome coronavirus 2, paediatric, children, adolescent and infant. The search strategy is provided in [Supplementary Appendix S1](#sup1){ref-type="supplementary-material"}. No language restrictions were applied.

Study selection
---------------

A pre-defined set of the criterion was used for study selection for this systematic review. Initially, two researchers (J.Y. and J.M.) independently screened the title and abstract for the eligibility. Later all the authors examined full-text articles for inclusion and exclusion criteria. We included all types of studies (case report, case series and observational) describing radiological findings of confirmed SARS-CoV-2 infection in children aged \<19 years. Studies reporting other serotypes of coronavirus, narrative or systematic review, editorial, perspective, etc. not meeting the inclusion criteria were excluded.

Data extraction and quality assessment
--------------------------------------

A well-structured, standardized proforma was used for data extraction. Four investigators (J.Y., J.K., J.M. and A.Y.) independently extracted data from the full text of the eligible studies. Extracted data include first author name, year, country, journal, study design, study population information for risk of bias assessment of the study, method and type of sample used for confirmation of SARS-CoV-2 infection, age and gender distribution of cases, the clinical status of the subjects (symptomatic/asymptomatic) and radiological findings.

As CT scan was the predominant modality used for imaging, we extracted data using a structured proforma mentioning the side of the lesion (left/right/both), lobes (upper, middle and lower), location (central/peripheral) and characteristic of the lesion (consolidation, ground glass, etc.). Any disagreement between two investigators was resolved through discussion with the third investigator (A.Y.). One researcher (J.K.) independently rechecked the extracted data for its accuracy as well as completeness and ensured that there is no duplication of included studies. The quality of the included studies in this systematic review was assessed using the Newcastle Ottawa scale. Three investigators (J.Y., J.K. and J.M.) independently assigned an overall risk of bias to each eligible study, and if they disagreed, another researcher (A.Y.) was called to resolve the discrepancy. Publication bias was considered high since all the included studies were either case series or case reports.

Data synthesis and statistical analysis
---------------------------------------

We presented the data with descriptive statistics and provided pooled estimates of various parameters, wherever it was feasible to meta-analyses the data. Percentages and mean values were calculated to describe categorical and continuous variables, respectively. Meta-analysed parameters were presented as pooled estimates with a 95% confidence interval (CI). Meta-analysis was performed using Stata version 14.2 (College Station, TX, USA). We pooled data from individual studies using a random effect model with the assumption that the frequency of radiological findings will be variable across the studies. Heterogeneity in studies was explored by inspection of forest plot as well as using the *χ*^2^ test on Cochran's *Q* statistics. Study heterogeneity was assessed by using the Higgins and Thompson *I*^2^ method \[[@fmaa045-B4]\]. The *I*^2^ heterogeneity was categorized as follows: 0--50% low, 50--75% moderate and \>75% considerable heterogeneity. To explore the heterogeneity, we performed sensitivity and subgroup analysis.

RESULTS
=======

Characteristics of included studies
-----------------------------------

After removing 1022 duplicates, 962 records were screened through titles and abstracts for eligibility for this systematic review ([Fig. 1](#fmaa045-F1){ref-type="fig"}). After the removal of 810 irrelevant articles, 152 full-text articles were assessed for inclusion in this study. Finally, we included 46 articles; of these 34 were case series (three or more cases) \[[@fmaa045-B5]\] and 12 case reports \[[@fmaa045-B39]\], with 923 patients with COVID-19. Characteristics of all eligible studies are described in [Table 1](#fmaa045-T1){ref-type="table"}. Among included studies, 17 are of fair quality and rest 19 are of poor quality. Forty-two of the included studies are from China, two from Italy and one each from Korea and Lebanon.
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###### 

Details of studies included in systematic review (n=46)

  Author                                  Publication date (DD-MM-YYYY)   Country   Total patients   Age (range)                 Quality of study
  --------------------------------------- ------------------------------- --------- ---------------- --------------------------- ------------------
  Bai, *et al*. \[[@fmaa045-B5]\]         22-04-2020                      China     25               0.6--17 years               Fair
  Cai, *et al*. \[[@fmaa045-B6]\]         28-02-2020                      China     10               3 months--10.91 years       Poor
  Chen, *et al*. \[[@fmaa045-B7]\]        22-03-2020                      China     12               6 months--17 years          Poor
  Denina, *et al*. \[[@fmaa045-B52]\]     21-04-2020                      Italy     8                0--17 years                 Poor
  Duan W, *et al*. \[[@fmaa045-B9]\]      03-02-2020                      China     30               0.5--17 years               Fair
  Feng, *et al*. \[[@fmaa045-B11]\]       02-05-2020                      China     5                1--18 years                 Poor
  Feng Kai, *et al*. \[[@fmaa045-B10]\]   02-04-2020                      China     15               4--14 years                 Fair
  Li B, *et al*. \[[@fmaa045-B13]\]       07-04-2020                      China     22               2--8 years                  Fair
  Li W, *et al*. \[[@fmaa045-B13]\]       11-03-2020                      China     5                10 months--6 years          Poor
  Li Y, *et al*. \[[@fmaa045-B12]\]       07-04-2020                      China     8                1--5 years                  Poor
  Liu M, *et al*. \[[@fmaa045-B17]\]      06-05-2020                      China     5                7 months--13 years          Poor
  Liu H, *et al*. \[[@fmaa045-B15]\]      02-03-2020                      China     4                2 months--11 years          Poor
  Liu W, *et al.* \[[@fmaa045-B16]\]      12-03-2020                      China     6                1--7 years                  Poor
  Lu, *et al*. \[[@fmaa045-B18]\]         18-03-2020                      China     111              1 day--15 years             Fair
  Lu, *et al*. \[[@fmaa045-B19]\]         28-04-2020                      China     9                2 months--12 years          Fair
  Ma, *et al*. \[[@fmaa045-B20]\]         06-05-2020                      China     50               0.9--9.8 years              Fair
  Parri, *et al*. \[[@fmaa045-B21]\]      01-05-2020                      Italy     18               0--17.5 years               Fair
  Qiu, *et al*. \[[@fmaa045-B22]\]        25-03-2020                      China     19               1--16 years                 Fair
  Shen, *et al*. \[[@fmaa045-B23]\]       23-03-2020                      China     9                1--12 years                 Poor
  Song, *et al*. \[[@fmaa045-B24]\]       16-04-2020                      China     16               11 months--14 years         Poor
  Su, *et al*. \[[@fmaa045-B25]\]         12-03-2020                      China     9                2 years 9 months--9 years   Poor
  Sun, *et al*. \[[@fmaa045-B26]\]        02-03-2020                      China     8                2 months--15 years          Poor
  Tan, *et al*. \[[@fmaa045-B27]\]        03-04-2020                      China     10               13 months--11 years         Fair
  Wu, *et al*. \[[@fmaa045-B28]\]         06-05-2020                      China     74               0.10--15.08 years           Fair
  Xia, *et al*. \[[@fmaa045-B29]\]        05-05-2020                      China     20               1 day--14 years             Fair
  Xin, *et al*. \[[@fmaa045-B30]\]        30-03-2020                      China     13               2--17 years                 Fair
  Xing, *et al*. \[[@fmaa045-B31]\]       25-03-2020                      China     3                1.5--6 years                Poor
  Xu, *et al*. \[[@fmaa045-B32]\]         13-03-2020                      China     10               2 months--16 years          Poor
  Yao-Ling, *et al*. \[[@fmaa045-B33]\]   16-03-2020                      China     115              1 month--15 years           Fair
  Zhang, *et al*. \[[@fmaa045-B34]\]      30-04-2020                      China     46               7 months--18 years          Fair
  Zheng, *et al*. \[[@fmaa045-B35]\]      10-03-2020                      China     24               1 month--14 years           Fair
  Zhong, *et al*. \[[@fmaa045-B36]\]      28-03-2020                      China     9                3 months--12 years          Poor
  Zhou, *et al*. \[[@fmaa045-B37]\]       01-03-2020                      China     9                0--3 years                  Poor
  Zhu, *et al*. \[[@fmaa045-B38]\]        01-06-2020                      China     10               1--18 years                 Fair
  Case reports (*n*-12)                                                                                                          
  Cui, *et al*. \[[@fmaa045-B40]\]        17-03-2020                      China     1                55 days                     NA
  Ji, *et al*. \[[@fmaa045-B50]\]         16-03-2020                      China     2                15 years, 9 years           NA
  Jiang, *et al*. \[[@fmaa045-B39]\]      05-04-2020                      China     2                6 years 8 months            NA
  Mansour, *et al*. \[[@fmaa045-B41]\]    04-03-2020                      Lebanon   1                16 months                   NA
  Li, *et al*. \[[@fmaa045-B46]\]         20-04-2020                      China     1                8 months                    NA
  Lin, *et al*. \[[@fmaa045-B47]\]        04-03-020                       China     1                7 years                     NA
  Mao, *et al*. \[[@fmaa045-B45]\]        07-05-2020                      China     1                14 months                   NA
  Pan, *et al*. \[[@fmaa045-B43]\]        19-02-2020                      China     1                3 years                     NA
  Park, *et al*. \[[@fmaa045-B42]\]       16-03-2020                      Korea     1                10 years                    NA
  Qiu, *et al*. \[[@fmaa045-B48]\]        13-04-2020                      China     1                8 months                    NA
  Xu, *et al*. \[[@fmaa045-B44]\]         01-03-2020                      China     1                10 years                    NA
  Zhang, *et al*. \[[@fmaa045-B49]\]      01-03-2020                      China     2                1 year 3 months             NA

NA, quality of study not assessed.

Radiology findings
------------------

Thirty-four case series reported data of 908 participants of which imaging details are provided for 747 (82.3%) only. Among these 747 patients, the clinical details were available for 722 (97%) patients (521 symptomatic, 201 asymptomatic). Chest CT was the commonest imaging modality (96.1%), followed by chest X-ray (8.2%) and chest ultrasound (3%).

Among the clinically symptomatic ones (*n* = 521 patients), 92 (17.6%) did not have any identifiable radiological abnormality, whereas 19% of clinically asymptomatic (38 of 201) patients had significant radiological findings. Overall, almost one-third (38%, 95% CI 28--42, *I*^2^ = 70%) of the patients who underwent imaging had a normal scan.

All the abnormal scans were further classified according to the type and size of the lesion. The exact description of the side of lung involvement was available for 263 patients only of which 143 (55%) have unilateral lung involvement and rest (45%) have bilateral lung involvement. The location of the lesion was mentioned for 55 only of which 44 (80%) lesions were located in the peripheral zone. The lower lobe of the right lung (40%) was most commonly involved followed by the upper lobe of the right lung (28%), lower lobe of the left lung (17%), middle lobe of the right lung (9%) and upper lobe of the left lung (6%).

Ground-glass opacity (GGO) was the most frequently reported radiological abnormality (32 studies and 706 patients) with pooled estimate in 39% (95% CI 31--48) of the patients. Patchy shadow (of undefined attenuation) was reported in 13 studies (246 patients) with a pooled estimate of 44% (95% CI 32--55). Consolidation was reported in 12 studies (192 patients) with a pooled estimate of 23% (95% CI 12--34). Other commonly reported abnormalities were halo sign, prominent bronchovascular marking, pleural effusion, bronchial wall thickening and pulmonary nodules ([Table 2](#fmaa045-T2){ref-type="table"}). To explore the high heterogeneity in pooled estimate, we performed sensitivity analysis did not find any specific study affecting the overall pooled estimates. On subgroup analysis according to quality of study, no significant difference was observed in pooled estimated of poor and fair quality study groups.

###### 

 Common radiological findings in children with SARS-CoV-2 infection

  Radiological finding                  No. of studies (patients)   Pooled estimates % (95% CI)   Heterogeneity % (*I*^2^)   *P*-value for heterogeneity
  ------------------------------------- --------------------------- ----------------------------- -------------------------- -----------------------------
  Ground glass opacity                  32 (706)                    39 (31--48)                   82                         0.00
  Consolidation                         12 (192)                    23 (12--34)                   82                         0.00
  Halo sign                             6 (78)                      26 (11--41)                   51                         0.09
  Patchy shadow                         13 (246)                    44 (32--55)                   62                         0.00
  Prominent bronchiovascular markings   5 (97)                      17 (09--24)                   0.0                        0.83
  Bronchial wall thickening             4 (36)                      11 (1--21)                    0.0                        1.00
  Pleural effusion                      5 (187)                     2 (0.1--4)                    0.0                        0.60
  Interstitial pattern                  4 (187)                     12 (1--23)                    82                         0.00
  Nodules                               5 (63)                      25 (9--41)                    62                         0.03

Three studies directly compared a chest X-ray with a chest CT scan \[[@fmaa045-B11], [@fmaa045-B31], [@fmaa045-B32]\]. Of the 18 patients, only 3 patients had positive chest X-ray findings, whereas chest CT identified radiological abnormalities in 10 patients. Point of care ultrasound is an emerging modality in COVID-19. Three studies evaluated its role in a total of 23 patients \[[@fmaa045-B11], [@fmaa045-B51], [@fmaa045-B52]\]. The commonest finding was pulmonary interstitial syndrome (seen in 19 of 23 patients) followed by small consolidation. One study directly compared chest CT, X-ray and lung ultrasound (LUS) in five patients and found that ultrasound fares better than X-ray and successfully identified two of the three abnormal cases \[[@fmaa045-B11]\].

In this systematic review, we also included 12 case reports \[[@fmaa045-B39]\] with COVID-19. Of these 12 patients had chest CT alone, one had X-ray only and one had both. Of the 15 patients, 8 did not have any radiological abnormality while among the remaining 2 had GGO alone, 2 had GGO and consolidation, 2 each have consolidation and shadows and 1 had GGO along with consolidation and pleural effusion.

DISCUSSION
==========

We found that the chest CT scan was the commonest imaging modality performed in children with confirmed COVID-19. Overall, one-third of patients did not have any radiological abnormality. Significant proportions (19%) of clinically asymptomatic but RT-PCR proven COVID-19 patients have radiological findings, suggesting that the chest CT can detect the infection before the appearance of clinical signs. GGOs are the commonest radiological lesion seen in COVID-19. Most of the lesions are located peripherally with the lower lobe of the right lung being the most common location. A chest X-ray is insensitive in identifying COVID-19 pneumonia. LUS fares better than X-ray but more evidence is needed.

Similar to adults, CT scan is the most frequently used radiological imaging modality. Alike adults, children too have GGOs as the most frequently reported radiological finding \[[@fmaa045-B1], [@fmaa045-B53]\]. Also, similar to adults the pulmonary lesions are peripherally distributed and have multilobar involvement in most of the cases. However, the incidence of radiological abnormalities is higher in adults. As high as one-third of the chest CT may not show any radiological evidence in children, whereas only 10--15% cases in adults may show a normal CT \[[@fmaa045-B1], [@fmaa045-B53]\]. Also, unlike adults where most of the lesions (∼80%) are bilateral, the distribution seems in children almost same in both lungs individually \[[@fmaa045-B1], [@fmaa045-B53]\]. Chest CT has been recommended as a screening tool in adults due to its higher sensitivity than RT PCR (98% vs. 71%, respectively) in initial stages of disease, however, similar data for children are lacking \[[@fmaa045-B54]\]. But a significant proportion of clinically asymptomatic children can be detected on chest CT.

The concern with the use of CT scan in children lies in the radiation exposure, which leads to exploring LUS as an imaging modality in COVID-19 \[[@fmaa045-B51], [@fmaa045-B52]\]. Since it is a point of care tool and most of the intensivists are more experienced with bedside LUS than CT, its role in the emergency department is likely to increase further \[[@fmaa045-B51]\]. Also, COVID-19 causes diffuse interstitial pneumonia with lesions involving mainly the peripheral lung, which makes it particularly suitable for use of LUS. The 'light beam sign' is considered an early as well as a specific marker of COVID-19 pneumonia on LUS \[[@fmaa045-B55]\]. However, this modality is still evolving and further research on it is likely to enlighten us further.

As many of the included studies were limited by sample size, methodological quality and variation in reporting of imaging findings leading to significant heterogeneity, the results (particularly pooled estimates) should be interpreted cautiously. Also, due to very limited data availability, we could not correlate the imaging findings with the disease severity, disease progression and outcomes.

CONCLUSIONS
===========

In the paediatric age group, a chest CT scan is the most common imaging modality used in COVID pneumonia. GGO followed by patchy shadows and consolidation are the most frequently reported radiological findings. LUS is an emerging modality and needs further exploration.

Supplementary Material
======================

###### 

Click here for additional data file.
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